Literature DB >> 20809066

Brain iron metabolism and its perturbation in neurological diseases.

Robert R Crichton1, David T Dexter, Roberta J Ward.   

Abstract

Metal ions are of particular importance in brain function, notably iron. A broad overview of iron metabolism and its homeostasis both at the cellular level (involving regulation at the level of mRNA translation) and the systemic level (involving the peptide 'hormone' hepcidin) is presented. The mechanisms of iron transport both across the blood-brain barrier and within the brain are then examined. The importance of iron in the developing foetus and in early life is underlined. We then review the growing corpus of evidence that many neurodegenerative diseases (NDs) are the consequence of dysregulation of brain iron homeostasis. This results in the production of reactive oxygen species, generating reactive aldehydes, which, together with further oxidative insults, causes oxidative modification of proteins, manifested by carbonyl formation. These misfolded and damaged proteins overwhelm the ubiquitin/proteasome system, accumulating the characteristic inclusion bodies found in many NDs. The involvement of iron in Alzheimer's disease and Parkinson's disease is then examined, with emphasis on recent data linking in particular interactions between iron homeostasis and key disease proteins. We conclude that there is overwhelming evidence for a direct involvement of iron in NDs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809066     DOI: 10.1007/s00702-010-0470-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  76 in total

Review 1.  Protein oxidation in aging, disease, and oxidative stress.

Authors:  B S Berlett; E R Stadtman
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

Review 2.  Brain iron metabolism and neurodegenerative disorders.

Authors:  Jack C Sipe; Pauline Lee; Ernest Beutler
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

3.  Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

Authors:  M Hashimoto; L J Hsu; Y Xia; A Takeda; A Sisk; M Sundsmo; E Masliah
Journal:  Neuroreport       Date:  1999-03-17       Impact factor: 1.837

4.  A novel lipid hydroperoxide-derived cyclic covalent modification to histone H4.

Authors:  Tomoyuki Oe; Jasbir S Arora; Seon Hwa Lee; Ian A Blair
Journal:  J Biol Chem       Date:  2003-08-20       Impact factor: 5.157

Review 5.  Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.

Authors:  Sandro Altamura; Martina U Muckenthaler
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 6.  Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.

Authors:  Anthony H V Schapira; C Warren Olanow
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

7.  The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain.

Authors:  Torben Moos; Evan H Morgan
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

Review 8.  The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions.

Authors:  N G Seidah; M Chrétien; R Day
Journal:  Biochimie       Date:  1994       Impact factor: 4.079

9.  Studies on the mechanism of iron release from transferrin.

Authors:  E H Morgan
Journal:  Biochim Biophys Acta       Date:  1979-10-24

10.  Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.

Authors:  S Arawaka; Y Saito; S Murayama; H Mori
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

View more
  71 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 2.  Iron chaperones for mitochondrial Fe-S cluster biosynthesis and ferritin iron storage.

Authors:  Poorna Subramanian; Andria V Rodrigues; Sudipa Ghimire-Rijal; Timothy L Stemmler
Journal:  Curr Opin Chem Biol       Date:  2011-01-31       Impact factor: 8.822

Review 3.  Iron and the immune system.

Authors:  Roberta J Ward; Robert R Crichton; Deanna L Taylor; Laura Della Corte; Surjit K Srai; David T Dexter
Journal:  J Neural Transm (Vienna)       Date:  2010-09-29       Impact factor: 3.575

4.  Lipocalin 2 modulates the cellular response to amyloid beta.

Authors:  S D Mesquita; A C Ferreira; A M Falcao; J C Sousa; T G Oliveira; M Correia-Neves; N Sousa; F Marques; J A Palha
Journal:  Cell Death Differ       Date:  2014-05-23       Impact factor: 15.828

5.  Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury.

Authors:  Sang Mi Lee; Steven Rosen; Philip Weinstein; Nico van Rooijen; Linda J Noble-Haeusslein
Journal:  J Neurotrauma       Date:  2011-08-08       Impact factor: 5.269

6.  Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice.

Authors:  Pavle Matak; Andrija Matak; Sarah Moustafa; Dipendra K Aryal; Eric J Benner; William Wetsel; Nancy C Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

7.  A reappraisal of Fe(III) adsorption by melanin.

Authors:  Rhiannon Lee Schroeder; Jacobus Petrus Gerber
Journal:  J Neural Transm (Vienna)       Date:  2014-05-21       Impact factor: 3.575

8.  A role for iron deficiency in dopaminergic neurodegeneration.

Authors:  Yvette Y Yien; Barry H Paw
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-16       Impact factor: 11.205

9.  Mfn2-Mediated Preservation of Mitochondrial Function Contributes to the Protective Effects of BHAPI in Response to Ischemia.

Authors:  Xiao-Li Chen; Guo-Ping Zhang; Sheng-Long Guo; Jia-Qi Ding; Jia-Ji Lin; Qian Yang; Zhu-Yi Li
Journal:  J Mol Neurosci       Date:  2017-09-26       Impact factor: 3.444

10.  A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.

Authors:  Swati Haldar; 'alim J Beveridge; Joseph Wong; Ajay Singh; Daniela Galimberti; Barbara Borroni; Xiongwei Zhu; Janis Blevins; Justin Greenlee; George Perry; Chinmay K Mukhopadhyay; Christine Schmotzer; Neena Singh
Journal:  Antioxid Redox Signal       Date:  2013-04-16       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.